GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial aims to shrink tumors before stomach cancer surgery
Disease control OngoingThis study is testing whether combining immunotherapy and targeted drugs with standard chemotherapy before surgery can better shrink tumors in people with advanced stomach or gastroesophageal junction cancer. The goal is to see if this approach leads to more complete tumor remova…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug cocktail aims to shrink tumors before surgery, boost survival after
Disease control OngoingThis study is testing whether adding two newer drugs (apatinib and camrelizumab) to standard chemotherapy helps people with advanced stomach cancer. The treatment is given both before surgery to shrink the tumor and after surgery to try to prevent the cancer from coming back. Res…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC